|
|
TIOTROPIUM | OLODATEROL
|
|
|
|
|
|
ANTICHOLINERGIC AGENTS (RESPIRATORY)
|
|
|
As for Vilanterol/Fluticasone (See p. 365).Prophylaxis of asthma; Long-term maintenance of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD).
|
|
|
As for Vilanterol/Fluticasone.Close monitoring for glaucoma and cataracts is warranted. Do not use in combination with an additional LABA because of risk ofoverdose. Naso-pharyngitis, upper respiratory tract infection, head ache, and oral candidiasis. After inhalation, the patient should rinse his/her mouth with water without swallowing to help reduce the risk of oropharyngeal candidiasis
|
|
|
Two puffs once daily, at the same time each day .
|
|
|
|
|
|
|
|
|
|
|
|
|